C E Ford
Overview
Explore the profile of C E Ford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
147
Citations
3556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuwono N, Alonso A, Abbott J, Houshdaran S, Henry C, Rodgers R, et al.
Hum Reprod
. 2022 Sep;
37(11):2560-2569.
PMID: 36166696
Study Question: Is circulating cell-free DNA (cirDNA) from the endometrium elevated during menstruation and in endometriosis? Summary Answer: Endometrial cirDNA does not increase during menstruation and is not elevated in...
2.
Henry C, Llamosas E, Djordjevic A, Hacker N, Ford C
Oncogenesis
. 2022 Jun;
11(1):32.
PMID: 35676255
No abstract available.
3.
Henry C, Llamosas E, Daniels B, Coopes A, Tang K, Ford C
Gynecol Oncol
. 2018 Feb;
148(3):576-584.
PMID: 29395309
Objective: In recent years, the Wnt signalling pathway and the ROR1 and ROR2 receptors have been implicated in a range of gynecological cancers. These receptors have been described as prospective...
4.
Henry C, Emmanuel C, Lambie N, Loo C, Kan B, Kennedy C, et al.
Transl Oncol
. 2017 Mar;
10(3):346-356.
PMID: 28342318
Objective: The ROR1 and ROR2 receptor tyrosine kinases have both been implicated in ovarian cancer progression and have been shown to drive migration and invasion. There is an increasing importance...
5.
Henry C, Llamosas E, Djordjevic A, Hacker N, Ford C
Oncogenesis
. 2016 May;
5(5):e226.
PMID: 27239958
Ovarian cancer survival remains poor despite recent advances in our understanding of genetic profiles. Unfortunately, the majority of ovarian cancer patients have recurrent disease after chemotherapy and lack other treatment...
6.
Do A, Lynch A, Claas S, Boerwinkle E, Davis B, Ford C, et al.
J Hum Hypertens
. 2016 Jan;
30(9):549-54.
PMID: 26791477
African Americans have the highest prevalence of hypertension in the United States. Blood pressure (BP) control is important to reduce cardiovascular disease-related morbidity and mortality in this ethnic group. Genetic...
7.
Ford C, Henry C, Llamosas E, Djordjevic A, Hacker N
Gynecol Oncol
. 2015 Oct;
140(2):345-51.
PMID: 26432042
The three major gynaecological cancers, ovarian, uterine and cervical, contribute a significant burden to global cancer mortality, and affect women in both developed and developing countries. However, unlike other cancer...
8.
Henry C, Quadir A, Hawkins N, Jary E, Llamosas E, Kumar D, et al.
J Cancer Res Clin Oncol
. 2014 Sep;
141(2):243-54.
PMID: 25209439
Purpose: Wnt signalling has been implicated in breast cancer, and in particular aberrant β-catenin-independent Wnt signalling has been associated with breast cancer metastasis and Tamoxifen resistance. Despite Wnt pathway involvement...
9.
Ford C, Punnia-Moorthy G, Henry C, Llamosas E, Nixdorf S, Olivier J, et al.
Gynecol Oncol
. 2014 Jun;
134(2):338-45.
PMID: 24924122
Objective: Aberrant Wnt signalling has previously been associated with gynaecological cancers, and the aim of this study was to investigate the expression of Wnt5a in epithelial ovarian cancer, and clarify...
10.
Barnes D, Ford C, Gray S, LOUTIT J
Prog Nucl Energy 6 Biol Sci
. 2014 Feb;
2:1-10.
PMID: 24546347
No abstract available.